Inari Medical, Inc. (NARI)
Whether directors and officers of Inari Medical, Inc. (NARI) breached their fiduciary duties to the company and its shareholders.
Investigation
05/10/2022
Initial Lawsuit
07/06/2022
Lawsuit Progression
09/05/2022
Did Unity Software Inc. (U) mislead investors regarding the accuracy of its machine learning technology, notably its Audience Pinpointer tool?
This post is open for investors to gather facts, and findings and track their exposure to related lawsuits. We invite investors and shareholders to contribute to this investigation for their own benefit, add events to the factual timeline below and vote on events’ pertinence.
A lawsuit was subsequently filed. We will update this post as it unfolds.
05/10/2022
During the conference call, executives explained the slow-down in revenue from its Operate segment:
“Operate started the year strong in January, but then significantly slowed down in February and March . . . While there are external factors to consider, the Operate challenge is mostly caused by internal factors in Unity monetization in an otherwise healthy market. We see these challenges as temporary and not structural and do not expect them to impact future prospects of our business beyond 2022. The most succinct framing for the challenges we are facing is that we built more for growth and less for resiliency. Following years of rapid growth and working through the challenges of Apple’s privacy changes, we got hit hard by two issues.
Stock Impact
Close | Previous close | Price variation | Percentage variation |
---|---|---|---|
$30.3 | $48.13 | $-17.83 | -37.05% |
A Unity Software Inc. (U) shareholder filed a federal securities class action on behalf of a class consisting of all persons and entities (other than the listed defendants) that purchased or otherwise acquired Unity securities between March 5, 2021 and May 10, 2022, both dates inclusive.
According to the complaint, defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the company’s business, operations, and prospects. Specifically, defendants allegedly failed to disclose to investors that:
(i) deficiencies in Unity’s product platform reduced the accuracy of the company’s machine learning technology;
(ii) the foregoing was likely to have a material negative impact on the company’s revenues;
(iii) accordingly, Unity had overstated the company’s commercial and/or financial prospects for 2022;
(iv) as a result, the company was likely to have to reduce its fiscal 2022 guidance; and
(v) as aresult, the company’s public statements were materially false and misleading at all relevant times.
The lead plaintiff deadline has passed, we will update this page as the lawsuit progresses.
Last event retrieved on 09/27/2022.
Whether directors and officers of Inari Medical, Inc. (NARI) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Amicus Therapeutics, Inc. (FOLD) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Kewaunee Scientific Corporation (KEQU) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of LegalZoom.com, Inc. (LZ) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Payoneer Global Inc. (PAYO) breached their fiduciary duties to the company and its shareholders.
Confidential investigation: officers & directors’ potential breach of fiduciary duties to investors.